N@N

ACOR, MELA, FREE, IGOI, TEAR, REFR Are Seasonally Ripe To Go Down In the Next Five Weeks

November 29, 2011 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of ACORDA THERAPEUTICS INC (NASDAQ:ACOR), MELA SCIENCES INC (NASDAQ:MELA), FreeSeas Inc. - Common Stock (NASDAQ:FREE), IGO INC (NASDAQ:IGOI), TEARLAB CORP (NASDAQ:TEAR), RESEARCH FRONTIERS INC (NASDAQ:REFR) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php

The following stocks are expected to go Down:

     Symbol     Company                             Expected Return     Odds                    By The Following Date
     ACOR       ACORDA THERAPEUTICS INC             -6.62%              100.00% (5 of 5)        Friday, December 9th 2011
     MELA       MELA SCIENCES INC                   -13.18%             66.67% (4 of 6)         Friday, December 16th 2011
     FREE       FreeSeas Inc. - Common Stock        -7.69%              100.00% (5 of 5)        Wednesday, December 7th 2011
     IGOI       IGO INC                             -17.64%             90.91% (10 of 11)       Tuesday, January 3rd 2012
     TEAR       TEARLAB CORP                        -6.23%              100.00% (6 of 6)        Wednesday, December 7th 2011
     REFR       RESEARCH FRONTIERS INC              -4.12%              100.00% (11 of 11)      Wednesday, December 7th 2011

ACORDA THERAPEUTICS INC (NASDAQ:ACOR) - Acorda Therapeutics, Inc., a biotechnology company, develops therapies for multiple sclerosis, spinal cord injury, and other nervous system disorders. Its marketed products include Ampyra (dalfampridine), a potassium channel blocker for improving walking in patients with multiple sclerosis; and Zanaflex Capsules and Zanaflex tablets (tizanidine hydrochloride), a short-acting drug for the management of spasticity. The companys pipeline also includes various products in development for the treatment, regeneration, and repair of the spinal cord and brain. Its preclinical products comprise remyelination programs that include two distinct therapeutic approaches to stimulate repair of the damaged myelin sheath in multiple sclerosis, neuregulins/glial growth factor 2, and remyelinating antibodies; and chondroitinase program, which develops second generation approaches to overcoming the proteoglycan matrix. Acorda Therapeutics sells its products through specialty sales force, managed care team, and contract pharmaceutical telesales organizations. The company was founded in 1995 and is based in Hawthorne, New York.

MELA SCIENCES INC (NASDAQ:MELA) - MELA Sciences, Inc. operates as a medical device company that focuses on the design and development of a non-invasive, point-of-care instrument to assist in the early diagnosis of melanoma. The companys principal product, MelaFind, features a hand-held imaging device that emits multiple wavelengths of light to capture images of suspicious pigmented skin lesions and extract data. This product uses automatic image analysis and statistical pattern recognition to help identify lesions to be considered for biopsy to rule out melanoma. It consists of hand-held imaging device, which employs high precision optics and multi-spectral illumination; database of pigmented skin lesions; and lesion classifiers, which are mathematical algorithms that extract lesion feature information and classify lesions. MELA Sciences filed the MelaFind pre-market approval application with the U.S. Food and Drug Administration (FDA) in June 2009 and is under review at the FDA. The company was formerly known as Electro-Optical Sciences, Inc. and changed its name MELA Sciences, Inc. in April 2010. MELA Sciences was founded in 1989 and is based in Irvington, New York.

FreeSeas Inc. - Common Stock (NASDAQ:FREE) - FreeSeas Inc., incorporated in April 2004, is a Marshall Islands corporation operating out of Piraeus, Greece. The Company is engaged in the transportation of dry bulk cargoes through the ownership and operation of drybulk vessels. It has a fleet of three Handysize vessels. The Company operates through its wholly owned subsidiaries, Adventure Two, S.A., Adventure Three, S.A. and Adventure Four, S.A. The operations of the vessels are managed by Free Bulkers, an affiliated Marshall Islands corporation. Free Bulkers provides FreeSeas with a wide range of shipping services at a fixed monthly fee per vessel. These services include technical management, such as managing day-to-day vessel operations including supervising the crewing, supplying, maintaining and drydocking of vessels, commercial management regarding identifying suitable vessel charter opportunities and certain accounting services.

On March 24 2005, Trinity Partners Acquisition Company Inc. (Trinity), which was a black check company, and FreeSeas entered into an agreement and plan of merger providing for the merger of Trinity into FreeSeas. On December 16, 2005, the Company announced that it had completed its merger with Trinity, and in accordance with the terms of the merger, FreeSeas was the surviving corporation.

The operations of the Company's vessels are managed by Free Bulkers S.A. (Free Bulkers), an affiliated company. Free Bulkers provides FreeSeas with a range of shipping services at a fixed monthly fee per vessel. These services include technical management, such as managing day-to-day vessel operations, including supervising the crewing, supplying, maintaining and dry docking of vessels, commercial management regarding identifying suitable vessel charter opportunities, and certain accounting services.

During the year ended December 31, 2004, one charterer, Express Sea Transport Corporation, chartered both M/V Free Destiny and the M/V Free Envoy. Until the acquisition of the M/V Free Fighter, FreeSeas' only sources of revenue were the charters by Express Sea Transport Corporation. The M/V Free Fighter is being chartered by other charterers.

The Company competes with Dryships Inc., Diana Shipping Inc., Eagle Bulk Shipping Inc. and Excel Maritime Carriers Ltd.

IGO INC (NASDAQ:IGOI) - iGo, Inc. and its subsidiaries engage in the design, development, manufacture, and distribution of power products for high-power and low-power mobile electronic devices. The companys products include AC/DC universal power adapters, DC-only power adapters, AC-only power adapters, DC cigarette lighter adapters, mobile AC adapters, combination AC/DC adapters, and battery-powered adapters. It also provides mobile device accessories, such as monitor stands, portable computer stands, and foldable keyboards. The company offers its power products for portable computers, mobile phones, smartphones, portable digital assistants, digital cameras, MP3 players, portable game consoles, and other handheld devices. iGo, Inc. markets and sells its products to original equipment manufacturers, private-label resellers, retailers, resellers, distributors, and wireless carriers, as well as directly to end users through its iGo.com Website under the iGo and iGo Green brand names. It operates in North America, Europe, and the Asia Pacific. The company was formerly known as Mobility Electronics, Inc. and changed its name to iGo, Inc. in May 2008. iGo, Inc. was founded in 1995 and is based in Scottsdale, Arizona.

TEARLAB CORP (NASDAQ:TEAR) - TearLab Corporation is an ophthalmic device company and engages in commercializing a proprietary in vitro diagnostic tear testing platform, the TearLab test for dry eye disease. Its TearLab Osmolarity System enables eye care practitioners to test for highly sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. The companys TearLab Osmolarity System consists of the TearLab disposable, a single-use microfluidic labcard; the TearLab pen, a hand-held device, which interfaces with the TearLab disposable; and the TearLab reader, a small desktop unit that allows for the docking of the TearLab disposable and the TearLab pen, as well as provides a quantitative reading for the operator. It sells its products through distributors in Europe, Asia, and North America. TearLab Corporation was formerly known as OccuLogix, Inc. and changed its name to TearLab Corporation on May 17, 2010. TearLab Corporation was founded in 1996 and is headquartered in San Diego, California.

RESEARCH FRONTIERS INC (NASDAQ:REFR) - Research Frontiers Incorporated engages in the development, licensing, and marketing of technology and devices to control the flow of light. The company licenses its suspended particle device (SPD-Smart) light-control technology to companies that manufacture and market the SPD-smart chemical emulsion, light-control film made from chemical emulsion, lamination services, and electronics to power end-products incorporating the film; and end-products, such as windows, skylights, and sunroofs. The SPD-Smart light-control technology is used for various applications, such as windows, skylights, partitions, doors, and sunshades for the architectural, aircraft, marine, automotive, and appliance industries; variable light transmission sunglasses, goggles, visors, and other eyewear; variable light transmission automotive sunroofs, sunvisors, and rear-view mirrors; and flat panel information displays for use in billboards, scoreboards, point-of-purchase advertising displays, traffic signs, computers, telephones, PDAs, and other electronic instruments. The company was founded in 1965 and is headquartered in Woodbury, New York.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641